NCT02027480View on ClinicalTrials.gov

Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study

CompletedOBSERVATIONAL
Enrollment

685

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
HIV (Human Immunodeficiency Virus)AIDS (Acquired Immune Deficiency Syndrome)TuberculosisNon-communicable Diseases (NCD)
Trial Locations (9)

Unknown

Ahero Sub District Hospital, Ahero

Ambira Sub District Hospital, Ambira

Awasi Mission, Awasi

Bondo District Hospital, Bondo

Nyakach District Hospital, Kisumu

Masogo Sub District Hospital, Masogo

Nyangoma Dispensary, Nyangoma

Sigomere Health Centre, Sigomere

Sondu Health Center, Sondu

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Columbia University

OTHER

NCT02027480 - Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study | Biotech Hunter | Biotech Hunter